Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,215Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Allergan Inc.

02 1Bausch Health, Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Tazarotene

Brand Name : TAZORAC

Patent Number : 2191773

Filing Date : 1995-06-07

Strength per Unit : 0.05%

Dosage Form : Gel

Human Or VET : Human

Route of Administration : Topical

Patent Expiration Date : 2015-08-10

Date Granted : 2004-08-10

Abbvie CB

02

Tazarotene

Brand Name : TAZORAC

Patent Number : 2191773

Filing Date : 1995-06-07

Strength per Unit : 0.10%

Dosage Form : Gel

Human Or VET : Human

Route of Administration : Topical

Patent Expiration Date : 2015-08-10

Date Granted : 2004-08-10

Abbvie CB

03

Bausch Health, Canada Inc.

arrow
Peptide Process CMC
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Halobetasol, Tazarotene

Brand Name : DUOBRII

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01% w / w ; 0.045% w / w

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

blank